Evidence map›Paper›PMID 37894513›Full record

ArticleMolecules (Basel, Switzerland)2023

Fabrication of Antibacterial and Antioxidant ZnO-Impregnated Amine-Functionalized Chitosan Bio-Nanocomposite Membrane for Advanced Biomedical Applications.

Ali M Ali, Abdelrahman M Hamed, Mahmoud A Taher, Mohamed H Abdallah, Mohamed Abdel-Motaleb, Zyta M Ziora, Ahmed M Omer

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Biofabrication ofPharmaceutics · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ali M AliChemistry Department, Faculty of Science, AL-Azhar University, Assiut 71524, Egypt.
Abdelrahman M HamedChemistry Department, Faculty of Science, AL-Azhar University, Assiut 71524, Egypt.
Mahmoud A TaherChemistry Department, Faculty of Science, AL-Azhar University, Assiut 71524, Egypt.
Mohamed H AbdallahChemistry Department, Faculty of Science, AL-Azhar University, Assiut 71524, Egypt.
Mohamed Abdel-MotalebChemistry Department, Faculty of Science, AL-Azhar University, Assiut 71524, Egypt.
Zyta M ZioraInstitute for Molecular Bioscience, University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia.ORCID 0000-0002-9664-3101
Ahmed M OmerPolymer Institute of the Slovak Academy of Sciences, Dúbravská Cesta 9, 845 41 Bratislava, Slovakia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developing a variety of safe and effective functioning wound dressings is a never-ending objective. Due to their exceptional antibacterial activity, biocompatibility, biodegradability, and healing-promoting properties, functionalized chitosan nanocomposites have attracted considerable attention in wound dressing applications. Herein, a novel bio-nanocomposite membrane with a variety of bio-characteristics was created through the incorporation of zinc oxide nanoparticles (ZnONPs) into amine-functionalized chitosan membrane (Am-CS). The developed ZnO@Am-CS bio-nanocomposite membrane was characterized by various analysis tools. Compared to pristine Am-CS, the developed ZnO@Am-CS membrane revealed higher water uptake and adequate mechanical properties. Moreover, increasing the ZnONP content from 0.025 to 0.1% had a positive impact on antibacterial activity against Gram-positive and Gram-negative bacteria. A maximum inhibition of 89.4% was recorded against

Indexed as

ChitosanNanocompositesZinc OxideAnti-Bacterial AgentsAntioxidantsGram-Negative BacteriaGram-Positive BacteriaAnti-Bacterial AgentsAntioxidantsChitosanZinc Oxideaminated chitosanantibacterial activityantioxidant activitybiodegradable membraneZnO nanoparticles

Identifiers

PMID37894513
PMCPMC10608820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.